-
1
-
-
1442299315
-
Nonalcoholic fatty liver disease in patients with type 2 diabetes
-
DOI 10.1016/S1542-3565(04)00014-X, PII S154235650400014X
-
Younossi ZM, Gramlich T, Matteoni CA, Boparai N, Mc-Cullough AJ. Nonalcoholic fatty liver disease in patients with type 2 diabetes. Clin Gastroenterol Hepatol 2004; 2: 262-265 [PMID: 15017611 DOI: 10.1053/S1542-3565(04)00014-X] (Pubitemid 38293314)
-
(2004)
Clinical Gastroenterology and Hepatology
, vol.2
, Issue.3
, pp. 262-265
-
-
Younossi, Z.M.1
Gramlich, T.2
Matteoni, C.A.3
Boparai, N.4
McCullough, A.J.5
-
2
-
-
27644510019
-
Review article: Type 2 diabetes and chronic liver disease in the Verona diabetes study
-
Trombetta M, Spiazzi G, Zoppini G, Muggeo M. Review article: type 2 diabetes and chronic liver disease in the Verona diabetes study. Aliment Pharmacol Ther 2005; 22 Suppl 2: 24-27 [PMID: 16225467 DOI: 10.1111/j.1365-2036.2005.02590.x] (Pubitemid 41564377)
-
(2005)
Alimentary Pharmacology and Therapeutics, Supplement
, vol.22
, Issue.2
, pp. 24-27
-
-
Trombetta, M.1
Spiazzi, G.2
Zoppini, G.3
Muggeo, M.4
-
3
-
-
34247605492
-
Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients
-
DOI 10.2337/dc06-2247
-
Targher G, Bertolini L, Padovani R, Rodella S, Tessari R, Zenari L, Day C, Arcaro G. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 2007; 30: 1212-1218 [PMID: 17277038 DOI: 10.2337/dc06-2247] (Pubitemid 46684650)
-
(2007)
Diabetes Care
, vol.30
, Issue.5
, pp. 1212-1218
-
-
Targher, G.1
Bertolini, L.2
Padovani, R.3
Rodella, S.4
Tessari, R.5
Zenari, L.6
Day, C.7
Arcaro, G.8
-
4
-
-
57749183469
-
Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus
-
PMID: 18384521
-
Leite NC, Salles GF, Araujo AL, Villela-Nogueira CA, Cardoso CR. Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus. Liver Int 2009; 29: 113-119 [PMID: 18384521 DOI: 10.1111/j.1478-3231.2008.01718.x]
-
(2009)
Liver Int
, vol.29
, pp. 113-119
-
-
Leite, N.C.1
Salles, G.F.2
Araujo, A.L.3
Villela-Nogueira, C.A.4
Cardoso, C.R.5
-
5
-
-
68949129467
-
Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus
-
PMID: 19588648
-
Prashanth M, Ganesh HK, Vima MV, John M, Bandgar T, Joshi SR, Shah SR, Rathi PM, Joshi AS, Thakkar H, Menon PS, Shah NS. Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. J Assoc Physicians India 2009; 57: 205-210 [PMID: 19588648]
-
(2009)
J Assoc Physicians India
, vol.57
, pp. 205-210
-
-
Prashanth, M.1
Ganesh, H.K.2
Vima, M.V.3
John, M.4
Bandgar, T.5
Joshi, S.R.6
Shah, S.R.7
Rathi, P.M.8
Joshi, A.S.9
Thakkar, H.10
Menon, P.S.11
Shah, N.S.12
-
6
-
-
79953321393
-
Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: Prevalences and correlated factors
-
PMID: 21457442
-
Leite NC, Villela-Nogueira CA, Pannain VL, Bottino AC, Rezende GF, Cardoso CR, Salles GF. Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors. Liver Int 2011; 31: 700-706 [PMID: 21457442 DOI: 10.1111/j.1478-3231.2011.02482.x]
-
(2011)
Liver Int
, vol.31
, pp. 700-706
-
-
Leite, N.C.1
Villela-Nogueira, C.A.2
Pannain, V.L.3
Bottino, A.C.4
Rezende, G.F.5
Cardoso, C.R.6
Salles, G.F.7
-
7
-
-
11144351102
-
The histological course of nonalcoholic fatty liver disease: A longitudinal study of 103 patients with sequential liver biopsies
-
DOI 10.1016/j.jhep.2004.09.012, PII S0168827804004350
-
Adams LA, Sanderson S, Lindor KD, Angulo P. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J Hepatol 2005; 42: 132-138 [PMID: 15629518 DOI: 10.1016/j.jhep.2004.09.012] (Pubitemid 40038911)
-
(2005)
Journal of Hepatology
, vol.42
, Issue.1
, pp. 132-138
-
-
Adams, L.A.1
Sanderson, S.2
Lindor, K.D.3
Angulo, P.4
-
8
-
-
33750606061
-
Long-term follow-up of patients with NAFLD and elevated liver enzymes
-
DOI 10.1002/hep.21327
-
Ekstedt M, Franzén LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, Kechagias S. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006; 44: 865-873 [PMID: 17006923 DOI: 10.1002/hep.21327] (Pubitemid 46489550)
-
(2006)
Hepatology
, vol.44
, Issue.4
, pp. 865-873
-
-
Ekstedt, M.1
Franzen, L.E.2
Mathiesen, U.L.3
Thorelius, L.4
Holmqvist, M.5
Bodemar, G.6
Kechagias, S.7
-
9
-
-
77955463534
-
Newly diagnosed diabetes mellitus as a risk factor for serious liver disease
-
PMID: 20566726
-
Porepa L, Ray JG, Sanchez-Romeu P, Booth GL. Newly diagnosed diabetes mellitus as a risk factor for serious liver disease. CMAJ 2010; 182: E526-E531 [PMID: 20566726 DOI: 10.1503/cmaj.092144]
-
(2010)
CMAJ
, vol.182
, pp. E526-E531
-
-
Porepa, L.1
Ray, J.G.2
Sanchez-Romeu, P.3
Booth, G.L.4
-
10
-
-
0034799113
-
Ninety patients with nonalcoholic steatohepatitis: Insulin resistance, familial tendency, and severity of disease
-
DOI 10.1016/S0002-9270(01)03229-4, PII S0002927001032294
-
Willner IR, Waters B, Patil SR, Reuben A, Morelli J, Riely CA. Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease. Am J Gastroenterol 2001; 96: 2957-2961 [PMID: 11693332 DOI: 10.1111/j.1572-0241.2001.04667.x] (Pubitemid 32959539)
-
(2001)
American Journal of Gastroenterology
, vol.96
, Issue.10
, pp. 2957-2961
-
-
Willner, I.R.1
Waters, B.2
Patil, S.R.3
Reuben, A.4
Morelli, J.5
Riely, C.A.6
-
11
-
-
80555136061
-
Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity
-
PMID: 21039302
-
Musso G, Gambino R, Cassader M, Pagano G. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 2011; 43: 617-649 [PMID: 21039302 DOI: 10.3109/07853890.2010.518623]
-
(2011)
Ann Med
, vol.43
, pp. 617-649
-
-
Musso, G.1
Gambino, R.2
Cassader, M.3
Pagano, G.4
-
12
-
-
33645774428
-
Nonalcoholic steatohepatitis (NASH) with diabetes: Predictors of liver fibrosis
-
PMID: 16531962
-
Amarapurka DN, Amarapurkar AD, Patel ND, Agal S, Baigal R, Gupte P, Pramanik S. Nonalcoholic steatohepatitis (NASH) with diabetes: predictors of liver fibrosis. Ann Hepatol 2006; 5: 30-33 [PMID: 16531962]
-
(2006)
Ann Hepatol
, vol.5
, pp. 30-33
-
-
Amarapurka, D.N.1
Amarapurkar, A.D.2
Patel, N.D.3
Agal, S.4
Baigal, R.5
Gupte, P.6
Pramanik, S.7
-
13
-
-
4143100133
-
Non-alcoholic steatohepatitis in type 2 diabetes mellitus
-
DOI 10.1111/j.1440-1746.2004.03312.x
-
Gupte P, Amarapurkar D, Agal S, Baijal R, Kulshrestha P, Pramanik S, Patel N, Madan A, Amarapurkar A. Non-alcoholic steatohepatitis in type 2 diabetes mellitus. J Gastroenterol Hepatol 2004; 19: 854-858 [PMID: 15242486 DOI: 10.1111/j.1440-1746.2004.03312.x] (Pubitemid 39093200)
-
(2004)
Journal of Gastroenterology and Hepatology
, vol.19
, Issue.8
, pp. 854-858
-
-
Gupte, P.1
Amarapurkar, D.2
Agal, S.3
Baijal, R.4
Kulshrestha, P.5
Pramanik, S.6
Patel, N.7
Madan, A.8
Amarapurkar, A.9
Hafeezunnisa10
-
14
-
-
0019152816
-
Nonalcoholic steatohepatitis. Mayo Clinic experiences with a hitherto unnamed disease
-
Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980; 55: 434-438 [PMID: 7382552] (Pubitemid 10057164)
-
(1980)
Mayo Clinic Proceedings
, vol.55
, Issue.7
, pp. 434-438
-
-
Ludwig, J.1
Viggiano, T.R.2
McGill, D.B.3
Ott, B.J.4
-
15
-
-
0033038672
-
Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity
-
DOI 10.1016/S0016-5085(99)70506-8
-
Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 1413-1419 [PMID: 10348825 DOI: 10.1016/S0016-5085(99)70506-8] (Pubitemid 29258890)
-
(1999)
Gastroenterology
, vol.116
, Issue.6
, pp. 1413-1419
-
-
Matteoni, C.A.1
Younossi, Z.M.2
Gramlich, T.3
Boparai, N.4
Yao, C.L.5
McCullough, A.J.6
-
16
-
-
0033200054
-
Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions
-
DOI 10.1111/j.1572-0241.1999.01377.x, PII S0002927099004335
-
Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander- Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999; 94: 2467-2474 [PMID: 10484010 DOI: 10.1111/j.1572-0241.1999.01377.x] (Pubitemid 29420675)
-
(1999)
American Journal of Gastroenterology
, vol.94
, Issue.9
, pp. 2467-2474
-
-
Brunt, E.M.1
Janney, C.G.2
Di, B.A.M.3
Neuschwander-Tetri, B.A.4
Bacon, B.R.5
-
17
-
-
20044374023
-
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
-
DOI 10.1002/hep.20701
-
Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp- Arida A, Yeh M, McCullough AJ, Sanyal AJ. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41: 1313-1321 [PMID: 15915461 DOI: 10.1002/hep.20701] (Pubitemid 40770284)
-
(2005)
Hepatology
, vol.41
, Issue.6
, pp. 1313-1321
-
-
Kleiner, D.E.1
Brunt, E.M.2
Van Natta, M.3
Behling, C.4
Contos, M.J.5
Cummings, O.W.6
Ferrell, L.D.7
Liu, Y.-C.8
Torbenson, M.S.9
Unalp-Arida, A.10
Yeh, M.11
McCullough, A.J.12
Sanyal, A.J.13
-
18
-
-
0037129380
-
Nonalcoholic fatty liver disease
-
PMID: 11961152
-
Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346: 1221-1231 [PMID: 11961152 DOI: 10.1056/NEJMra011775]
-
(2002)
N Engl J Med
, vol.346
, pp. 1221-1231
-
-
Angulo, P.1
-
19
-
-
6844258880
-
Drinking habits as cofactors of risk for alcohol induced liver damage
-
The Dionysos Study Group PMID: 9462221
-
Bellentani S, Saccoccio G, Costa G, Tiribelli C, Manenti F, Sodde M, Saveria Crocè L, Sasso F, Pozzato G, Cristianini G, Brandi G. Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group. Gut 1997; 41: 845-850 [PMID: 9462221]
-
(1997)
Gut
, vol.41
, pp. 845-850
-
-
Bellentani, S.1
Saccoccio, G.2
Costa, G.3
Tiribelli, C.4
Manenti, F.5
Sodde, M.6
Saveria Crocè, L.7
Sasso, F.8
Pozzato, G.9
Cristianini, G.10
Brandi, G.11
-
20
-
-
34250326350
-
Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: Executive summary
-
DOI 10.1111/j.1440-1746.2007.05002.x
-
Farrell GC, Chitturi S, Lau GK, Sollano JD. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary. J Gastroenterol Hepatol 2007; 22: 775-777 [PMID: 17565629 DOI: 10.1111/j.1440-1746.2007.05002.x] (Pubitemid 46911045)
-
(2007)
Journal of Gastroenterology and Hepatology
, vol.22
, Issue.6
, pp. 775-777
-
-
Farrell, G.C.1
Chitturi, S.2
Lau, G.K.K.3
Sollano, J.D.4
-
21
-
-
33644547706
-
Nonalcoholic fatty liver disease: From steatosis to cirrhosis
-
PMID: 16447287
-
Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006; 43: S99-S112 [PMID: 16447287 DOI: 10.1002/hep.20973]
-
(2006)
Hepatology
, vol.43
, pp. S99-S112
-
-
Farrell, G.C.1
Larter, C.Z.2
-
22
-
-
10644220306
-
Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity
-
DOI 10.1002/hep.20466
-
Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM, Hobbs HH. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004; 40: 1387-1395 [PMID: 15565570 DOI: 10.1002/hep.20466] (Pubitemid 39657013)
-
(2004)
Hepatology
, vol.40
, Issue.6
, pp. 1387-1395
-
-
Browning, J.D.1
Szczepaniak, L.S.2
Dobbins, R.3
Nuremberg, P.4
Horton, J.D.5
Cohen, J.C.6
Grundy, S.M.7
Hobbs, H.H.8
-
23
-
-
84887320114
-
The global NAFLD epidemic
-
PMID: 24042449
-
Loomba R, Sanyal AJ. The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol 2013; 10: 686-690 [PMID: 24042449 DOI: 10.1038/nrgastro.2013.171]
-
(2013)
Nat Rev Gastroenterol Hepatol
, vol.10
, pp. 686-690
-
-
Loomba, R.1
Sanyal, A.J.2
-
24
-
-
77954578209
-
An introduction of strategies for the management of nonalcoholic fatty liver disease (NAFLD) recommended by Asia Pacific Working Party on NAFLD
-
PMID: 17669255
-
Fan JG. [An introduction of strategies for the management of nonalcoholic fatty liver disease (NAFLD) recommended by Asia Pacific Working Party on NAFLD]. Zhonghua Gan Zang Bing Zazhi 2007; 15: 552-553 [PMID: 17669255]
-
(2007)
Zhonghua Gan Zang Bing Zazhi
, vol.15
, pp. 552-553
-
-
Fan, J.G.1
-
25
-
-
77952576769
-
Epidemiology of non-alcoholic fatty liver disease
-
PMID: 20460905
-
Bellentani S, Scaglioni F, Marino M, Bedogni G. Epidemiology of non-alcoholic fatty liver disease. Dig Dis 2010; 28: 155-161 [PMID: 20460905 DOI: 10.1159/000282080]
-
(2010)
Dig Dis
, vol.28
, pp. 155-161
-
-
Bellentani, S.1
Scaglioni, F.2
Marino, M.3
Bedogni, G.4
-
26
-
-
78650486196
-
Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: A prospective study
-
PMID: 20858492
-
Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, Landt CL, Harrison SA. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 2011; 140: 124-131 [PMID: 20858492 DOI: 10.1053/j.gastro.2010.09.038]
-
(2011)
Gastroenterology
, vol.140
, pp. 124-131
-
-
Williams, C.D.1
Stengel, J.2
Asike, M.I.3
Torres, D.M.4
Shaw, J.5
Contreras, M.6
Landt, C.L.7
Harrison, S.A.8
-
27
-
-
80053581540
-
Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States
-
PMID: 21726509
-
Charlton MR, Burns JM, Pedersen RA, Watt KD, Heimbach JK, Dierkhising RA. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology 2011; 141: 1249-1253 [PMID: 21726509 DOI: 10.1053/j.gastro.2011.06.061]
-
(2011)
Gastroenterology
, vol.141
, pp. 1249-1253
-
-
Charlton, M.R.1
Burns, J.M.2
Pedersen, R.A.3
Watt, K.D.4
Heimbach, J.K.5
Dierkhising, R.A.6
-
28
-
-
22344452893
-
The natural history of nonalcoholic fatty liver disease: A population-based cohort study
-
DOI 10.1053/j.gastro.2005.04.014, PII S0016508505006943
-
Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, Angulo P. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005; 129: 113-121 [PMID: 16012941 DOI: 10.1053/j.gastro.2005.04.014] (Pubitemid 41002048)
-
(2005)
Gastroenterology
, vol.129
, Issue.1
, pp. 113-121
-
-
Adams, L.A.1
Lymp, J.F.2
St., S.J.3
Sanderson, S.O.4
Lindor, K.D.5
Feldstein, A.6
Angulo, P.7
-
29
-
-
58849090967
-
Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis
-
PMID: 19148800
-
Hashimoto E, Yatsuji S, Tobari M, Taniai M, Torii N, Tokushige K, Shiratori K. Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. J Gastroenterol 2009;44 Suppl 19: 89-95 [PMID: 19148800 DOI: 10.1007/s00535-008-2262-x]
-
(2009)
J Gastroenterol
, vol.44
, pp. 89-95
-
-
Hashimoto, E.1
Yatsuji, S.2
Tobari, M.3
Taniai, M.4
Torii, N.5
Tokushige, K.6
Shiratori, K.7
-
30
-
-
37749004882
-
The metabolic syndrome in type 1 diabetes: Does it exist and does it matter?
-
PMID: 18191073
-
McGill M, Molyneaux L, Twigg SM, Yue DK. The metabolic syndrome in type 1 diabetes: does it exist and does it matter? J Diabetes Complications 2008; 22: 18-23 [PMID: 18191073 DOI: 10.1016/j.diacomp.2006.10.005]
-
(2008)
J Diabetes Complications
, vol.22
, pp. 18-23
-
-
McGill, M.1
Molyneaux, L.2
Twigg, S.M.3
Yue, D.K.4
-
31
-
-
77956266803
-
Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes
-
PMID: 20619918
-
Targher G, Bertolini L, Padovani R, Rodella S, Zoppini G, Pichiri I, Sorgato C, Zenari L, Bonora E. Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes. J Hepatol 2010; 53: 713-718 [PMID: 20619918 DOI: 10.1016/j.jhep.2010.04.030]
-
(2010)
J Hepatol
, vol.53
, pp. 713-718
-
-
Targher, G.1
Bertolini, L.2
Padovani, R.3
Rodella, S.4
Zoppini, G.5
Pichiri, I.6
Sorgato, C.7
Zenari, L.8
Bonora, E.9
-
32
-
-
84878241556
-
Nonalcoholic fatty liver disease and microvascular complications in type 2 diabetes
-
PMID: 23716995
-
Lv WS, Sun RX, Gao YY, Wen JP, Pan RF, Li L, Wang J, Xian YX, Cao CX, Zheng M. Nonalcoholic fatty liver disease and microvascular complications in type 2 diabetes. World J Gastroenterol 2013; 19: 3134-3142 [PMID: 23716995 DOI: 10.3748/wjg.v19.i20.3134]
-
(2013)
World J Gastroenterol
, vol.19
, pp. 3134-3142
-
-
Lv, W.S.1
Sun, R.X.2
Gao, Y.Y.3
Wen, J.P.4
Pan, R.F.5
Li, L.6
Wang, J.7
Xian, Y.X.8
Cao, C.X.9
Zheng, M.10
-
33
-
-
79956062113
-
Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: The Edinburgh Type 2 Diabetes Study
-
PMID: 21478462
-
Williamson RM, Price JF, Glancy S, Perry E, Nee LD, Hayes PC, Frier BM, Van Look LA, Johnston GI, Reynolds RM, Strachan MW. Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes Care 2011; 34: 1139-1144 [PMID: 21478462 DOI: 10.2337/dc10-2229]
-
(2011)
Diabetes Care
, vol.34
, pp. 1139-1144
-
-
Williamson, R.M.1
Price, J.F.2
Glancy, S.3
Perry, E.4
Nee, L.D.5
Hayes, P.C.6
Frier, B.M.7
Van Look, L.A.8
Johnston, G.I.9
Reynolds, R.M.10
Strachan, M.W.11
-
34
-
-
58849134985
-
Long-term follow-up of patients with nonalcoholic fatty liver
-
PMID: 19049831
-
Rafiq N, Bai C, Fang Y, Srishord M, McCullough A, Gramlich T, Younossi ZM. Long-term follow-up of patients with nonalcoholic fatty liver. Clin Gastroenterol Hepatol 2009; 7: 234-238 [PMID: 19049831 DOI: 10.1016/j.cgh.2008.11.005]
-
(2009)
Clin Gastroenterol Hepatol
, vol.7
, pp. 234-238
-
-
Rafiq, N.1
Bai, C.2
Fang, Y.3
Srishord, M.4
McCullough, A.5
Gramlich, T.6
Younossi, Z.M.7
-
35
-
-
34548337060
-
Histological progression of non-alcoholic fatty liver disease: A critical reassessment based on liver sampling variability
-
DOI 10.1111/j.1365-2036.2007.03425.x
-
Ratziu V, Bugianesi E, Dixon J, Fassio E, Ekstedt M, Charlotte F, Kechagias S, Poynard T, Olsson R. Histological progression of non-alcoholic fatty liver disease: a critical reassessment based on liver sampling variability. Aliment Pharmacol Ther 2007; 26: 821-830 [PMID: 17767466 DOI: 10.1111/j.1365-2036.2007.03425.x] (Pubitemid 47346702)
-
(2007)
Alimentary Pharmacology and Therapeutics
, vol.26
, Issue.6
, pp. 821-830
-
-
Ratziu, V.1
Bugianesi, E.2
Dixon, J.3
Fassio, E.4
Ekstedt, M.5
Charlotte, F.6
Kechagias, S.7
Poynard, T.8
Olsson, R.9
-
36
-
-
25844500757
-
Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass
-
DOI 10.1381/0960892055002347
-
Boza C, Riquelme A, Ibañez L, Duarte I, Norero E, Viviani P, Soza A, Fernandez JI, Raddatz A, Guzman S, Arrese M. Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass. Obes Surg 2005; 15: 1148-1153 [PMID: 16197788 DOI: 10.1381/0960892055002347] (Pubitemid 41390213)
-
(2005)
Obesity Surgery
, vol.15
, Issue.8
, pp. 1148-1153
-
-
Boza, C.1
Riquelme, A.2
Ibanez, L.3
Duarte, I.4
Norero, E.5
Viviani, P.6
Soza, A.7
Fernandez, J.I.8
Raddatz, A.9
Guzman, S.10
Arrese, M.11
-
37
-
-
20544439374
-
Hepatic histopathology of patients with morbid obesity submitted to gastric bypass
-
DOI 10.1381/0960892053923888
-
Lima ML, Mourão SC, Diniz MT, Leite VH. Hepatic histopathology of patients with morbid obesity submitted to gastric bypass. Obes Surg 2005; 15: 661-669 [PMID: 15946458] (Pubitemid 40847957)
-
(2005)
Obesity Surgery
, vol.15
, Issue.5
, pp. 661-669
-
-
Pereira, L.M.L.R.1
Oliveira, M.S.C.2
Costa, D.M.T.3
Rios, L.V.H.4
-
38
-
-
0001407283
-
High prevalence of NASH among Mexican American females with type II diabetes mellitus
-
abstract
-
Kemmer NM, Xiao SY, Singh H, Murray R, Abdo B. High prevalence of NASH among Mexican American females with type II diabetes mellitus. Gastroenterology 2001; 120 Suppl 1: A117 [abstract]
-
(2001)
Gastroenterology
, vol.120
, pp. A117
-
-
Kemmer, N.M.1
Xiao, S.Y.2
Singh, H.3
Murray, R.4
Abdo, B.5
-
39
-
-
38149030206
-
Liver fat is increased in type 2 diabetic patients and underestimated by serum alanine aminotransferase compared with equally obese nondiabetic subjects
-
PMID: 17934148
-
Kotronen A, Juurinen L, Hakkarainen A, Westerbacka J, Cornér A, Bergholm R, Yki-Järvinen H. Liver fat is increased in type 2 diabetic patients and underestimated by serum alanine aminotransferase compared with equally obese nondiabetic subjects. Diabetes Care 2008; 31: 165-169 [PMID: 17934148 DOI: 10.2337/dc07-1463]
-
(2008)
Diabetes Care
, vol.31
, pp. 165-169
-
-
Kotronen, A.1
Juurinen, L.2
Hakkarainen, A.3
Westerbacka, J.4
Cornér, A.5
Bergholm, R.6
Yki-Järvinen, H.7
-
40
-
-
84865545850
-
Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis
-
PMID: 22505194
-
Loomba R, Abraham M, Unalp A, Wilson L, Lavine J, Doo E, Bass NM. Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis. Hepatology 2012; 56: 943-951 [PMID: 22505194 DOI: 10.1002/hep.25772]
-
(2012)
Hepatology
, vol.56
, pp. 943-951
-
-
Loomba, R.1
Abraham, M.2
Unalp, A.3
Wilson, L.4
Lavine, J.5
Doo, E.6
Bass, N.M.7
-
41
-
-
80054116983
-
Risk of cardiovascular disease and chronic kidney disease in diabetic patients with non-alcoholic fatty liver disease: Just a coincidence?
-
PMID: 21427524
-
Targher G, Chonchol M, Pichiri I, Zoppini G. Risk of cardiovascular disease and chronic kidney disease in diabetic patients with non-alcoholic fatty liver disease: just a coincidence? J Endocrinol Invest 2011; 34: 544-551 [PMID: 21427524 DOI: 10.3275/7614]
-
(2011)
J Endocrinol Invest
, vol.34
, pp. 544-551
-
-
Targher, G.1
Chonchol, M.2
Pichiri, I.3
Zoppini, G.4
-
42
-
-
78650323871
-
Relationship between kidney function and liver histology in subjects with nonalcoholic steatohepatitis
-
PMID: 20724519
-
Targher G, Bertolini L, Rodella S, Lippi G, Zoppini G, Chonchol M. Relationship between kidney function and liver histology in subjects with nonalcoholic steatohepatitis. Clin J Am Soc Nephrol 2010; 5: 2166-2171 [PMID: 20724519 DOI: 10.2215/CJN.05050610]
-
(2010)
Clin J Am Soc Nephrol
, vol.5
, pp. 2166-2171
-
-
Targher, G.1
Bertolini, L.2
Rodella, S.3
Lippi, G.4
Zoppini, G.5
Chonchol, M.6
-
43
-
-
79954662342
-
Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: Is there a link?
-
PMID: 21145850
-
Targher G, Chonchol M, Zoppini G, Abaterusso C, Bonora E. Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: is there a link? J Hepatol 2011; 54: 1020-1029 [PMID: 21145850 DOI: 10.1016/j.jhep.2010.11.007]
-
(2011)
J Hepatol
, vol.54
, pp. 1020-1029
-
-
Targher, G.1
Chonchol, M.2
Zoppini, G.3
Abaterusso, C.4
Bonora, E.5
-
44
-
-
77955665639
-
Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and retinopathy in type 1 diabetic patients
-
PMID: 20369224
-
Targher G, Bertolini L, Chonchol M, Rodella S, Zoppini G, Lippi G, Zenari L, Bonora E. Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and retinopathy in type 1 diabetic patients. Diabetologia 2010; 53: 1341-1348 [PMID: 20369224 DOI: 10.1007/s00125-010-1720-1]
-
(2010)
Diabetologia
, vol.53
, pp. 1341-1348
-
-
Targher, G.1
Bertolini, L.2
Chonchol, M.3
Rodella, S.4
Zoppini, G.5
Lippi, G.6
Zenari, L.7
Bonora, E.8
-
45
-
-
84856708597
-
The relationship between arterial stiffness and nonalcoholic fatty liver disease
-
PMID: 21750929
-
Lee YJ, Shim JY, Moon BS, Shin YH, Jung DH, Lee JH, Lee HR. The relationship between arterial stiffness and nonalcoholic fatty liver disease. Dig Dis Sci 2012; 57: 196-203 [PMID: 21750929 DOI: 10.1007/s10620-011-1819-3]
-
(2012)
Dig Dis Sci
, vol.57
, pp. 196-203
-
-
Lee, Y.J.1
Shim, J.Y.2
Moon, B.S.3
Shin, Y.H.4
Jung, D.H.5
Lee, J.H.6
Lee, H.R.7
-
46
-
-
34247384560
-
The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD
-
DOI 10.1002/hep.21496
-
Angulo P, Hui JM, Marchesini G, Bugianesi E, George J, Farrell GC, Enders F, Saksena S, Burt AD, Bida JP, Lindor K, Sanderson SO, Lenzi M, Adams LA, Kench J, Therneau TM, Day CP. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 2007; 45: 846-854 [PMID: 17393509 DOI: 10.1002/hep.21496] (Pubitemid 46631552)
-
(2007)
Hepatology
, vol.45
, Issue.4
, pp. 846-854
-
-
Angulo, P.1
Hui, J.M.2
Marchesini, G.3
Bugianesi, E.4
George, J.5
Farrell, G.C.6
Enders, F.7
Saksena, S.8
Burt, A.D.9
Bida, J.P.10
Lindor, K.11
Sanderson, S.O.12
Lenzi, M.13
Adams, L.A.14
Kench, J.15
Therneau, T.M.16
Day, C.P.17
-
47
-
-
52649112178
-
Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease
-
PMID: 18390575
-
Harrison SA, Oliver D, Arnold HL, Gogia S, Neuschwander-Tetri BA. Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. Gut 2008; 57: 1441-1447 [PMID: 18390575 DOI: 10.1136/gut.2007.146019]
-
(2008)
Gut
, vol.57
, pp. 1441-1447
-
-
Harrison, S.A.1
Oliver, D.2
Arnold, H.L.3
Gogia, S.4
Neuschwander-Tetri, B.A.5
-
48
-
-
67649306197
-
Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis
-
PMID: 19501928
-
Argo CK, Northup PG, Al-Osaimi AM, Caldwell SH. Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis. J Hepatol 2009; 51: 371-379 [PMID: 19501928 DOI: 10.1016/j.jhep.2009.03.019]
-
(2009)
J Hepatol
, vol.51
, pp. 371-379
-
-
Argo, C.K.1
Northup, P.G.2
Al-Osaimi, A.M.3
Caldwell, S.H.4
-
49
-
-
20944450486
-
Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: Sites and mechanisms
-
DOI 10.1007/s00125-005-1682-x
-
Bugianesi E, Gastaldelli A, Vanni E, Gambino R, Cassader M, Baldi S, Ponti V, Pagano G, Ferrannini E, Rizzetto M. Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetologia 2005; 48: 634-642 [PMID: 15747110 DOI: 10.1007/s00125-005-1682-x] (Pubitemid 40591217)
-
(2005)
Diabetologia
, vol.48
, Issue.4
, pp. 634-642
-
-
Bugianesi, E.1
Gastaldelli, A.2
Vanni, E.3
Gambino, R.4
Cassader, M.5
Baldi, S.6
Ponti, V.7
Pagano, G.8
Ferrannini, E.9
Rizzetto, M.10
-
50
-
-
0342314436
-
Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients
-
Ryysy L, Häkkinen AM, Goto T, Vehkavaara S, Westerbacka J, Halavaara J, Yki-Järvinen H. Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. Diabetes 2000; 49: 749-758 [PMID: 10905483] (Pubitemid 30339990)
-
(2000)
Diabetes
, vol.49
, Issue.5
, pp. 749-758
-
-
Ryysy, L.1
Hakkinen, A.-M.2
Goto, T.3
Vehkavaara, S.4
Westerbacka, J.5
Halavaara, J.6
Yki-Jarvinen, H.7
-
51
-
-
79951634910
-
Postprandial hyperinsulinemia is universal in non-diabetic patients with nonalcoholic fatty liver disease
-
PMID: 21155882
-
Manchanayake J, Chitturi S, Nolan C, Farrell GC. Postprandial hyperinsulinemia is universal in non-diabetic patients with nonalcoholic fatty liver disease. J Gastroenterol Hepatol 2011; 26: 510-516 [PMID: 21155882 DOI: 10.1111/j.1440-1746.2010.06528.x]
-
(2011)
J Gastroenterol Hepatol
, vol.26
, pp. 510-516
-
-
Manchanayake, J.1
Chitturi, S.2
Nolan, C.3
Farrell, G.C.4
-
52
-
-
77952680758
-
Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: The Framingham Heart Study
-
PMID: 20336705
-
Speliotes EK, Massaro JM, Hoffmann U, Vasan RS, Meigs JB, Sahani DV, Hirschhorn JN, O'Donnell CJ, Fox CS. Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study. Hepatology 2010; 51: 1979-1987 [PMID: 20336705 DOI: 10.1002/hep.23593]
-
(2010)
Hepatology
, vol.51
, pp. 1979-1987
-
-
Speliotes, E.K.1
Massaro, J.M.2
Hoffmann, U.3
Vasan, R.S.4
Meigs, J.B.5
Sahani, D.V.6
Hirschhorn, J.N.7
O'Donnell, C.J.8
Fox, C.S.9
-
53
-
-
84873637593
-
Clinical Review: Nonalcoholic fatty liver disease: A novel cardiometabolic risk factor for type 2 diabetes and its complications
-
PMID: 23293330
-
Targher G, Byrne CD. Clinical Review: Nonalcoholic fatty liver disease: a novel cardiometabolic risk factor for type 2 diabetes and its complications. J Clin Endocrinol Metab 2013; 98: 483-495 [PMID: 23293330 DOI: 10.1210/jc.2012-3093]
-
(2013)
J Clin Endocrinol Metab
, vol.98
, pp. 483-495
-
-
Targher, G.1
Byrne, C.D.2
-
54
-
-
84871643501
-
Influence of non-alcoholic fatty liver disease on the development of diabetes mellitus
-
PMID: 22989165
-
Kasturiratne A, Weerasinghe S, Dassanayake AS, Rajindrajith S, de Silva AP, Kato N, Wickremasinghe AR, de Silva HJ. Influence of non-alcoholic fatty liver disease on the development of diabetes mellitus. J Gastroenterol Hepatol 2013; 28: 142-147 [PMID: 22989165 DOI: 10.1111/j.1440-1746.2012.07264.x]
-
(2013)
J Gastroenterol Hepatol
, vol.28
, pp. 142-147
-
-
Kasturiratne, A.1
Weerasinghe, S.2
Dassanayake, A.S.3
Rajindrajith, S.4
De Silva, A.P.5
Kato, N.6
Wickremasinghe, A.R.7
De Silva, H.J.8
-
55
-
-
84875259571
-
Increased risk of type 2 diabetes in subjects with both elevated liver enzymes and ultrasonographically diagnosed nonalcoholic fatty liver disease: A 4-year longitudinal study
-
PMID: 23398788
-
Choi JH, Rhee EJ, Bae JC, Park SE, Park CY, Cho YK, Oh KW, Park SW, Lee WY. Increased risk of type 2 diabetes in subjects with both elevated liver enzymes and ultrasonographically diagnosed nonalcoholic fatty liver disease: a 4-year longitudinal study. Arch Med Res 2013; 44: 115-120 [PMID: 23398788 DOI: 10.1016/j.arcmed.2013.01.007]
-
(2013)
Arch Med Res
, vol.44
, pp. 115-120
-
-
Choi, J.H.1
Rhee, E.J.2
Bae, J.C.3
Park, S.E.4
Park, C.Y.5
Cho, Y.K.6
Oh, K.W.7
Park, S.W.8
Lee, W.Y.9
-
56
-
-
79956074978
-
Combined effect of nonalcoholic fatty liver disease and impaired fasting glucose on the development of type 2 diabetes: A 4-year retrospective longitudinal study
-
PMID: 21278140
-
Bae JC, Rhee EJ, Lee WY, Park SE, Park CY, Oh KW, Park SW, Kim SW. Combined effect of nonalcoholic fatty liver disease and impaired fasting glucose on the development of type 2 diabetes: a 4-year retrospective longitudinal study. Diabetes Care 2011; 34: 727-729 [PMID: 21278140 DOI: 10.2337/dc10-1991]
-
(2011)
Diabetes Care
, vol.34
, pp. 727-729
-
-
Bae, J.C.1
Rhee, E.J.2
Lee, W.Y.3
Park, S.E.4
Park, C.Y.5
Oh, K.W.6
Park, S.W.7
Kim, S.W.8
-
57
-
-
84859404868
-
Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: Pathophysiology and clinical implications
-
PMID: 22326434
-
Cusi K . Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications. Gastroenterology 2012; 142: 711-725.e6 [PMID: 22326434 DOI: 10.1053/j.gastro.2012.02.003]
-
(2012)
Gastroenterology
, vol.142
, pp. 711-725.e6
-
-
Cusi, K.1
-
58
-
-
84859942552
-
Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease
-
PMID: 22183689
-
Lomonaco R, Ortiz-Lopez C, Orsak B, Webb A, Hardies J, Darland C, Finch J, Gastaldelli A, Harrison S, Tio F, Cusi K. Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease. Hepatology 2012; 55: 1389-1397 [PMID: 22183689 DOI: 10.1002/hep.25539]
-
(2012)
Hepatology
, vol.55
, pp. 1389-1397
-
-
Lomonaco, R.1
Ortiz-Lopez, C.2
Orsak, B.3
Webb, A.4
Hardies, J.5
Darland, C.6
Finch, J.7
Gastaldelli, A.8
Harrison, S.9
Tio, F.10
Cusi, K.11
-
59
-
-
4043077961
-
Molecular mediators of hepatic steatosis and liver injury
-
DOI 10.1172/JCI200422422
-
Browning JD, Horton JD. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 2004; 114: 147-152 [PMID: 15254578 DOI: 10.1172/JCI22422] (Pubitemid 39071617)
-
(2004)
Journal of Clinical Investigation
, vol.114
, Issue.2
, pp. 147-152
-
-
Browning, J.D.1
Horton, J.D.2
-
60
-
-
18244382304
-
Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease
-
DOI 10.1172/JCI200523621
-
Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 2005; 115: 1343-1351 [PMID: 15864352 DOI: 10.1172/JCI23621] (Pubitemid 40629054)
-
(2005)
Journal of Clinical Investigation
, vol.115
, Issue.5
, pp. 1343-1351
-
-
Donnelly, K.L.1
Smith, C.I.2
Schwarzenberg, S.J.3
Jessurun, J.4
Boldt, M.D.5
Parks, E.J.6
-
61
-
-
0036207720
-
Apolipoprotein synthesis in nonalcoholic steatohepatitis
-
DOI 10.1053/jhep.2002.32527
-
Charlton M, Sreekumar R, Rasmussen D, Lindor K, Nair KS. Apolipoprotein synthesis in nonalcoholic steatohepatitis. Hepatology 2002; 35: 898-904 [PMID: 11915037 DOI: 10.1053/jhep.2002.32527] (Pubitemid 34258385)
-
(2002)
Hepatology
, vol.35
, Issue.4
, pp. 898-904
-
-
Charlton, M.1
Sreekumar, R.2
Rasmussen, D.3
Lindor, K.4
Nair K.Sreekumaran5
-
62
-
-
77955690182
-
Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites
-
PMID: 20683968
-
Neuschwander-Tetri BA . Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites. Hepatology 2010; 52: 774-788 [PMID: 20683968 DOI: 10.1002/hep.23719]
-
(2010)
Hepatology
, vol.52
, pp. 774-788
-
-
Neuschwander-Tetri, B.A.1
-
63
-
-
0035084699
-
Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities
-
Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, Clore JN. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001; 120: 1183-1192 [PMID: 11266382 DOI: 10.1053/gast.2001.23256] (Pubitemid 32246672)
-
(2001)
Gastroenterology
, vol.120
, Issue.5
, pp. 1183-1192
-
-
Sanyal, A.J.1
Campbell-Sargent, C.2
Mirshahi, F.3
Rizzo, W.B.4
Contos, M.J.5
Sterling, R.K.6
Luketic, V.A.7
Shiffman, M.L.8
Clore, J.N.9
-
64
-
-
79959793959
-
Non-alcoholic steatohepatitis-induced fibrosis: Toll-like receptors, reactive oxygen species and Jun N-terminal kinase
-
PMID: 21711427
-
Brenner DA, Seki E, Taura K, Kisseleva T, Deminicis S, Iwaisako K, Inokuchi S, Schnabl B, Oesterreicher CH, Paik YH, Miura K, Kodama Y. Non-alcoholic steatohepatitis-induced fibrosis: Toll-like receptors, reactive oxygen species and Jun N-terminal kinase. Hepatol Res 2011; 41: 683-686 [PMID: 21711427 DOI: 10.1111/j.1872-034X.2011.00814.x]
-
(2011)
Hepatol Res
, vol.41
, pp. 683-686
-
-
Brenner, D.A.1
Seki, E.2
Taura, K.3
Kisseleva, T.4
Deminicis, S.5
Iwaisako, K.6
Inokuchi, S.7
Schnabl, B.8
Oesterreicher, C.H.9
Paik, Y.H.10
Miura, K.11
Kodama, Y.12
-
65
-
-
0141615879
-
Fatty liver in type 2 diabetes mellitus: Relation to regional adiposity, fatty acids, and insulin resistance
-
Kelley DE, McKolanis TM, Hegazi RA, Kuller LH, Kalhan SC. Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance. Am J Physiol Endocrinol Metab 2003; 285: E906-E916 [PMID: 12959938 DOI: 10.1152/ajpendo.00117.2003] (Pubitemid 37176440)
-
(2003)
American Journal of Physiology - Endocrinology and Metabolism
, vol.285
, Issue.4
, pp. E906-E916
-
-
Kelley, D.E.1
McKolanis, T.M.2
Hegazi, R.A.F.3
Kuller, L.H.4
Kalhana, S.C.5
-
66
-
-
79951810722
-
Serum total adiponectin in nonalcoholic fatty liver disease: A systematic review and meta-analysis
-
PMID: 21040935
-
Polyzos SA, Toulis KA, Goulis DG, Zavos C, Kountouras J. Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis. Metabolism 2011; 60: 313-326 [PMID: 21040935 DOI: 10.1016/j.metabol.2010.09.003]
-
(2011)
Metabolism
, vol.60
, pp. 313-326
-
-
Polyzos, S.A.1
Toulis, K.A.2
Goulis, D.G.3
Zavos, C.4
Kountouras, J.5
-
67
-
-
84876999954
-
Serum biomarkers in type 2 diabetic patients with non-alcoholic steatohepatitis and advanced fibrosis
-
PMID: 23067270
-
Leite NC, Salles GF, Cardoso CR, Villela-Nogueira CA. Serum biomarkers in type 2 diabetic patients with non-alcoholic steatohepatitis and advanced fibrosis. Hepatol Res 2013; 43: 508-515 [PMID: 23067270 DOI: 10.1111/j.1872-034X.2012.01106.x]
-
(2013)
Hepatol Res
, vol.43
, pp. 508-515
-
-
Leite, N.C.1
Salles, G.F.2
Cardoso, C.R.3
Villela-Nogueira, C.A.4
-
68
-
-
3042744737
-
Beyond insulin resistance in NASH: TNF-α or adiponectin?
-
DOI 10.1002/hep.20280
-
Hui JM, Hodge A, Farrell GC, Kench JG, Kriketos A, George J. Beyond insulin resistance in NASH: TNF-alpha or adiponectin? Hepatology 2004; 40: 46-54 [PMID: 15239085 DOI: 10.1002/hep.20280] (Pubitemid 38868922)
-
(2004)
Hepatology
, vol.40
, Issue.1
, pp. 46-54
-
-
Hui, J.M.1
Hodge, A.2
Farrell, G.C.3
Kench, J.G.4
Kriketos, A.5
George, J.6
-
69
-
-
57649214103
-
Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD)
-
PMID: 18824034
-
Musso G, Gambino R, Cassader M. Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). Prog Lipid Res 2009; 48: 1-26 [PMID: 18824034 DOI: 10.1016/j.plipres.2008.08.001]
-
(2009)
Prog Lipid Res
, vol.48
, pp. 1-26
-
-
Musso, G.1
Gambino, R.2
Cassader, M.3
-
70
-
-
0036839945
-
Eradication of small intestinal bacterial overgrowth and oro-cecal transit in diabetics
-
Cuoco L, Montalto M, Jorizzo RA, Santarelli L, Arancio F, Cammarota G, Gasbarrini G. Eradication of small intestinal bacterial overgrowth and oro-cecal transit in diabetics. Hepatogastroenterology 2002; 49: 1582-1586 [PMID: 12397741] (Pubitemid 35277332)
-
(2002)
Hepato-Gastroenterology
, vol.49
, Issue.48
, pp. 1582-1586
-
-
Cuoco, L.1
Montalto, M.2
Jorizzo, R.A.3
Santarelli, L.4
Arancio, F.5
Cammarota, G.6
Gasbarrini, G.7
-
71
-
-
56749096610
-
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
-
PMID: 18820647
-
Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, Pennacchio LA, Boerwinkle E, Cohen JC, Hobbs HH. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 2008; 40: 1461-1465 [PMID: 18820647 DOI: 10.1038/ng.257]
-
(2008)
Nat Genet
, vol.40
, pp. 1461-1465
-
-
Romeo, S.1
Kozlitina, J.2
Xing, C.3
Pertsemlidis, A.4
Cox, D.5
Pennacchio, L.A.6
Boerwinkle, E.7
Cohen, J.C.8
Hobbs, H.H.9
-
72
-
-
79957462315
-
Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease
-
PMID: 21381068
-
Sookoian S, Pirola CJ. Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease. Hepatology 2011; 53: 1883-1894 [PMID: 21381068 DOI: 10.1002/hep.24283]
-
(2011)
Hepatology
, vol.53
, pp. 1883-1894
-
-
Sookoian, S.1
Pirola, C.J.2
-
73
-
-
77956630787
-
PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease
-
PMID: 20648472
-
Speliotes EK, Butler JL, Palmer CD, Voight BF, Hirschhorn JN. PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease. Hepatology 2010; 52: 904-912 [PMID: 20648472 DOI: 10.1002/hep.23768]
-
(2010)
Hepatology
, vol.52
, pp. 904-912
-
-
Speliotes, E.K.1
Butler, J.L.2
Palmer, C.D.3
Voight, B.F.4
Hirschhorn, J.N.5
-
74
-
-
84855978332
-
The SOD2 C47T polymorphism influences NAFLD fibrosis severity: Evidence from case-control and intra-familial allele association studies
-
PMID: 21756849
-
Al-Serri A, Anstee QM, Valenti L, Nobili V, Leathart JB, Dongiovanni P, Patch J, Fracanzani A, Fargion S, Day CP, Daly AK. The SOD2 C47T polymorphism influences NAFLD fibrosis severity: evidence from case-control and intra-familial allele association studies. J Hepatol 2012; 56: 448-454 [PMID: 21756849 DOI: 10.1016/j.jhep.2011.05.029]
-
(2012)
J Hepatol
, vol.56
, pp. 448-454
-
-
Al-Serri, A.1
Anstee, Q.M.2
Valenti, L.3
Nobili, V.4
Leathart, J.B.5
Dongiovanni, P.6
Patch, J.7
Fracanzani, A.8
Fargion, S.9
Day, C.P.10
Daly, A.K.11
-
75
-
-
33745454996
-
A common functional exon polymorphism in the microsomal triglyceride transfer protein gene is associated with type 2 diabetes, impaired glucose metabolism and insulin levels
-
DOI 10.1007/s10038-006-0400-y
-
Rubin D, Helwig U, Pfeuffer M, Schreiber S, Boeing H, Fisher E, Pfeiffer A, Freitag-Wolf S, Foelsch UR, Doering F, Schrezenmeir J. A common functional exon polymorphism in the microsomal triglyceride transfer protein gene is associated with type 2 diabetes, impaired glucose metabolism and insulin levels. J Hum Genet 2006; 51: 567-574 [PMID: 16721486 DOI: 10.1007/s10038-006-0400-y] (Pubitemid 43954307)
-
(2006)
Journal of Human Genetics
, vol.51
, Issue.6
, pp. 567-574
-
-
Rubin, D.1
Helwig, U.2
Pfeuffer, M.3
Schreiber, S.4
Boeing, H.5
Fisher, E.6
Pfeiffer, A.7
Freitag-Wolf, S.8
Foelsch, U.R.9
Doering, F.10
Schrezenmeir, J.11
-
76
-
-
33846413204
-
Tamoxifen-induced non-alcoholic steatohepatitis: Where are we now and where are we going?
-
PMID: 17181445
-
Osman KA, Osman MM, Ahmed MH. Tamoxifen-induced non-alcoholic steatohepatitis: where are we now and where are we going? Expert Opin Drug Saf 2007; 6: 1-4 [PMID: 17181445 DOI: 10.1517/14740338.6.1.1]
-
(2007)
Expert Opin Drug Saf
, vol.6
, pp. 1-4
-
-
Osman, K.A.1
Osman, M.M.2
Ahmed, M.H.3
-
77
-
-
0036247430
-
Drugs and steatohepatitis
-
DOI 10.1055/s-2002-30106
-
Farrell GC. Drugs and steatohepatitis. Semin Liver Dis 2002; 22: 185-194 [PMID: 12016549 DOI: 10.1055/s-2002-30106] (Pubitemid 34496471)
-
(2002)
Seminars in Liver Disease
, vol.22
, Issue.2
, pp. 185-194
-
-
Farrell, G.C.1
-
78
-
-
79960125897
-
ASH and NASH
-
PMID: 21734385
-
Scaglioni F, Ciccia S, Marino M, Bedogni G, Bellentani S. ASH and NASH. Dig Dis 2011; 29: 202-210 [PMID: 21734385 DOI: 10.1159/000323886]
-
(2011)
Dig Dis
, vol.29
, pp. 202-210
-
-
Scaglioni, F.1
Ciccia, S.2
Marino, M.3
Bedogni, G.4
Bellentani, S.5
-
79
-
-
0037566201
-
Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values
-
DOI 10.1053/jhep.2003.50229
-
Mofrad P, Contos MJ, Haque M, Sargeant C, Fisher RA, Luketic VA, Sterling RK, Shiffman ML, Stravitz RT, Sanyal AJ. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology 2003; 37: 1286-1292 [PMID: 12774006 DOI: 10.1053/jhep.2003.50229] (Pubitemid 36667307)
-
(2003)
Hepatology
, vol.37
, Issue.6
, pp. 1286-1292
-
-
Mofrad, P.1
Contos, M.J.2
Haque, M.3
Sargeant, C.4
Fisher, R.A.5
Luketic, V.A.6
Sterling, R.K.7
Shiffman, M.L.8
Stravitz, R.T.9
Sanyal, A.J.10
-
80
-
-
24144481800
-
Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women
-
DOI 10.1002/hep.20818
-
Kunde SS, Lazenby AJ, Clements RH, Abrams GA. Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women. Hepatology 2005; 42: 650-656 [PMID: 16037946 DOI: 10.1002/hep.20818] (Pubitemid 41233658)
-
(2005)
Hepatology
, vol.42
, Issue.3
, pp. 650-656
-
-
Kunde, S.S.1
Lazenby, A.J.2
Clements, R.H.3
Abrams, G.A.4
-
81
-
-
84858825405
-
Serum ferritin levels do not predict the stage of underlying nonalcoholic fatty liver disease
-
PMID: 22457860
-
Chandok N, Minuk G, Wengiel M, Uhanova J. Serum ferritin levels do not predict the stage of underlying nonalcoholic fatty liver disease. J Gastrointestin Liver Dis 2012; 21: 53-58 [PMID: 22457860]
-
(2012)
J Gastrointestin Liver Dis
, vol.21
, pp. 53-58
-
-
Chandok, N.1
Minuk, G.2
Wengiel, M.3
Uhanova, J.4
-
82
-
-
84862903129
-
Clinical significance of serum autoantibodies in patients with NAFLD: Results from the nonalcoholic steatohepatitis clinical research network
-
May 10; Epub ahead of print PMID: 21557024
-
Vuppalanchi R, Gould RJ, Wilson LA, Unalp-Arida A, Cummings OW, Chalasani N, Kowdley KV; Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN). Clinical significance of serum autoantibodies in patients with NAFLD: results from the nonalcoholic steatohepatitis clinical research network. Hepatol Int 2011 May 10; Epub ahead of print [PMID: 21557024 DOI: 10.1007/s12072-011-9277-8]
-
(2011)
Hepatol Int
-
-
Vuppalanchi, R.1
Gould, R.J.2
Wilson, L.A.3
Unalp-Arida, A.4
Cummings, O.W.5
Chalasani, N.6
Kowdley, K.V.7
-
83
-
-
33846650863
-
Fatty liver and the metabolic syndrome
-
PMID: 17268250
-
Neuschwander-Tetri BA. Fatty liver and the metabolic syndrome. Curr Opin Gastroenterol 2007; 23: 193-198 [PMID: 17268250 DOI: 10.1097/MOG.0b013e32801421a9]
-
(2007)
Curr Opin Gastroenterol
, vol.23
, pp. 193-198
-
-
Neuschwander-Tetri, B.A.1
-
84
-
-
33846264060
-
Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: The plot thickens
-
DOI 10.1111/j.1464-5491.2007.02025.x
-
Targher G. Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens. Diabet Med 2007; 24: 1-6 [PMID: 17227317 DOI: 10.1111/j.1464-5491.2007.02025.x] (Pubitemid 46103064)
-
(2007)
Diabetic Medicine
, vol.24
, Issue.1
, pp. 1-6
-
-
Targher, G.1
-
85
-
-
84874193542
-
Diagnosis and management of nonalcoholic fatty liver disease and its hemostatic/thrombotic and vascular complications
-
PMID: 23397556
-
Targher G, Byrne CD. Diagnosis and management of nonalcoholic fatty liver disease and its hemostatic/thrombotic and vascular complications. Semin Thromb Hemost 2013; 39: 214-228 [PMID: 23397556 DOI: 10.1055/s-0033-1334866]
-
(2013)
Semin Thromb Hemost
, vol.39
, pp. 214-228
-
-
Targher, G.1
Byrne, C.D.2
-
86
-
-
0000491394
-
Diabetes and non-alcoholic fatty liver disease: A worrisome combination
-
abstract
-
Younossi Z, Matteoni C, Gramlich T, Boparai N, Price L, McCullough A. Diabetes and non-alcoholic fatty liver disease: A worrisome combination. Gastroenterology 1999; 116: A1292 [abstract]
-
(1999)
Gastroenterology
, vol.116
, pp. A1292
-
-
Younossi, Z.1
Matteoni, C.2
Gramlich, T.3
Boparai, N.4
Price, L.5
McCullough, A.6
-
87
-
-
70349546276
-
Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease
-
PMID: 19523535
-
Shah AG, Lydecker A, Murray K, Tetri BN, Contos MJ, Sanyal AJ. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2009; 7: 1104-1112 [PMID: 19523535 DOI: 10.1016/j.cgh.2009.05.033]
-
(2009)
Clin Gastroenterol Hepatol
, vol.7
, pp. 1104-1112
-
-
Shah, A.G.1
Lydecker, A.2
Murray, K.3
Tetri, B.N.4
Contos, M.J.5
Sanyal, A.J.6
-
88
-
-
56649112801
-
Diagnosis of nonalcoholic fatty liver disease: Invasive versus noninvasive
-
PMID: 18956295
-
Wieckowska A, Feldstein AE. Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive. Semin Liver Dis 2008; 28: 386-395 [PMID: 18956295 DOI: 10.1055/s-0028-1091983]
-
(2008)
Semin Liver Dis
, vol.28
, pp. 386-395
-
-
Wieckowska, A.1
Feldstein, A.E.2
-
90
-
-
0036729447
-
The utility of radiological imaging in nonalcoholic fatty liver disease
-
DOI 10.1053/gast.2002.35354
-
Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, Mullen KD, Cooper JN, Sheridan MJ. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 745-750 [PMID: 12198701] (Pubitemid 34977081)
-
(2002)
Gastroenterology
, vol.123
, Issue.3
, pp. 745-750
-
-
Saadeh, S.1
Younossi, Z.M.2
Remer, E.M.3
Gramlich, T.4
Ong, J.P.5
Hurley, M.6
Mullen, K.D.7
Cooper, J.N.8
Sheridan, M.J.9
-
91
-
-
0019473876
-
Prospective evaluation of the diagnostic accuracy of liver ultrasonography
-
Debongnie JC, Pauls C, Fievez M, Wibin E. Prospective evaluation of the diagnostic accuracy of liver ultrasonography. Gut 1981; 22: 130-135 [PMID: 7215943] (Pubitemid 11151029)
-
(1981)
Gut
, vol.22
, Issue.2
, pp. 130-135
-
-
Debongnie, J.C.1
Pauls, C.2
Fievez, M.3
Wibin, E.4
-
92
-
-
0018906287
-
The accuracy of ultrasound in the detection of fatty infiltration of the liver
-
Foster KJ, Dewbury KC, Griffith AH, Wright R. The accuracy of ultrasound in the detection of fatty infiltration of the liver. Br J Radiol 1980; 53: 440-442 [PMID: 7388276] (Pubitemid 10149583)
-
(1980)
British Journal of Radiology
, vol.53
, Issue.629
, pp. 440-442
-
-
Foster, K.J.1
Dewbury, K.C.2
Griffith, A.H.3
Wright, R.4
-
93
-
-
84865191383
-
Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD
-
PMID: 22520641
-
Ballestri S, Lonardo A, Romagnoli D, Carulli L, Losi L, Day CP, Loria P. Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD. Liver Int 2012; 32: 1242-1252 [PMID: 22520641 DOI: 10.1111/j.1478-3231.2012.02804.x]
-
(2012)
Liver Int
, vol.32
, pp. 1242-1252
-
-
Ballestri, S.1
Lonardo, A.2
Romagnoli, D.3
Carulli, L.4
Losi, L.5
Day, C.P.6
Loria, P.7
-
94
-
-
0347479217
-
Macrovesicular Hepatic Steatosis in Living Related Liver Donors: Correlation between CT and Histologic Findings
-
DOI 10.1148/radiol.2301021176
-
Limanond P, Raman SS, Lassman C, Sayre J, Ghobrial RM, Busuttil RW, Saab S, Lu DS. Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings. Radiology 2004; 230: 276-280 [PMID: 14695401 DOI: 10.1148/radiol.2301021176] (Pubitemid 37549813)
-
(2004)
Radiology
, vol.230
, Issue.1
, pp. 276-280
-
-
Limanond, P.1
Raman, S.S.2
Lassman, C.3
Sayre, J.4
Ghobrial, R.M.5
Busuttil, R.W.6
Saab, S.7
Lu, D.S.K.8
-
95
-
-
77953925097
-
Assessment of hepatic steatosis in patients undergoing liver resection: Comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy
-
PMID: 20574093
-
van Werven JR, Marsman HA, Nederveen AJ, Smits NJ, ten Kate FJ, van Gulik TM, Stoker J. Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy. Radiology 2010; 256: 159-168 [PMID: 20574093 DOI: 10.1148/radiol.10091790]
-
(2010)
Radiology
, vol.256
, pp. 159-168
-
-
Van Werven, J.R.1
Marsman, H.A.2
Nederveen, A.J.3
Smits, N.J.4
Ten Kate, F.J.5
Van Gulik, T.M.6
Stoker, J.7
-
96
-
-
79956292596
-
Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography
-
PMID: 21460032
-
Chen J, Talwalkar JA, Yin M, Glaser KJ, Sanderson SO, Ehman RL. Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography. Radiology 2011; 259: 749-756 [PMID: 21460032 DOI: 10.1148/radiol.11101942]
-
(2011)
Radiology
, vol.259
, pp. 749-756
-
-
Chen, J.1
Talwalkar, J.A.2
Yin, M.3
Glaser, K.J.4
Sanderson, S.O.5
Ehman, R.L.6
-
97
-
-
68049120181
-
Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance
-
PMID: 19604596
-
Schwenzer NF, Springer F, Schraml C, Stefan N, Machann J, Schick F. Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J Hepatol 2009; 51: 433-445 [PMID: 19604596 DOI: 10.1016/j.jhep.2009.05.023]
-
(2009)
J Hepatol
, vol.51
, pp. 433-445
-
-
Schwenzer, N.F.1
Springer, F.2
Schraml, C.3
Stefan, N.4
Machann, J.5
Schick, F.6
-
99
-
-
77958154016
-
Controlled attenuation parameter (CAP): A novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: Preliminary study and validation in a cohort of patients with chronic liver disease from various causes
-
PMID: 20870345
-
Sasso M, Beaugrand M, de Ledinghen V, Douvin C, Marcellin P, Poupon R, Sandrin L, Miette V. Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound Med Biol 2010; 36: 1825-1835 [PMID: 20870345 DOI: 10.1016/j.ultrasmedbio.2010.07.005]
-
(2010)
Ultrasound Med Biol
, vol.36
, pp. 1825-1835
-
-
Sasso, M.1
Beaugrand, M.2
De Ledinghen, V.3
Douvin, C.4
Marcellin, P.5
Poupon, R.6
Sandrin, L.7
Miette, V.8
-
100
-
-
84861981022
-
Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography
-
PMID: 22672642
-
de Lédinghen V, Vergniol J, Foucher J, Merrouche W, le Bail B. Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography. Liver Int 2012; 32: 911-918 [PMID: 22672642 DOI: 10.1111/j.1478-3231.2012.02820.x]
-
(2012)
Liver Int
, vol.32
, pp. 911-918
-
-
De Lédinghen, V.1
Vergniol, J.2
Foucher, J.3
Merrouche, W.4
Le Bail, B.5
-
101
-
-
75449091784
-
Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease
-
PMID: 20101745
-
Wong VW, Vergniol J, Wong GL, Foucher J, Chan HL, Le Bail B, Choi PC, Kowo M, Chan AW, Merrouche W, Sung JJ, de Lédinghen V. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology 2010; 51: 454-462 [PMID: 20101745 DOI: 10.1002/hep.23312]
-
(2010)
Hepatology
, vol.51
, pp. 454-462
-
-
Wong, V.W.1
Vergniol, J.2
Wong, G.L.3
Foucher, J.4
Chan, H.L.5
Le Bail, B.6
Choi, P.C.7
Kowo, M.8
Chan, A.W.9
Merrouche, W.10
Sung, J.J.11
De Lédinghen, V.12
-
102
-
-
77956119396
-
Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease
-
PMID: 20801772
-
McPherson S, Stewart SF, Henderson E, Burt AD, Day CP. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease. Gut 2010; 59: 1265-1269 [PMID: 20801772 DOI: 10.1136/gut.2010.216077]
-
(2010)
Gut
, vol.59
, pp. 1265-1269
-
-
McPherson, S.1
Stewart, S.F.2
Henderson, E.3
Burt, A.D.4
Day, C.P.5
-
103
-
-
0032695030
-
Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
-
PMID: 10573511
-
Angulo P, Keach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999; 30: 1356-1362 [PMID: 10573511]
-
(1999)
Hepatology
, vol.30
, pp. 1356-1362
-
-
Angulo, P.1
Keach, J.C.2
Batts, K.P.3
Lindor, K.D.4
-
104
-
-
33644607568
-
Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease
-
PMID: 16503961
-
Ratziu V, Massard J, Charlotte F, Messous D, Imbert-Bismut F, Bonyhay L, Tahiri M, Munteanu M, Thabut D, Cadranel JF, Le Bail B, de Ledinghen V, Poynard T. Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease. BMC Gastroenterol 2006; 6: 6 [PMID: 16503961]
-
(2006)
BMC Gastroenterol
, vol.6
, pp. 6
-
-
Ratziu, V.1
Massard, J.2
Charlotte, F.3
Messous, D.4
Imbert-Bismut, F.5
Bonyhay, L.6
Tahiri, M.7
Munteanu, M.8
Thabut, D.9
Cadranel, J.F.10
Le Bail, B.11
De Ledinghen, V.12
Poynard, T.13
-
105
-
-
39549118158
-
Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European liver fibrosis panel and exploring simple markers
-
DOI 10.1002/hep.21984
-
Guha IN, Parkes J, Roderick P, Chattopadhyay D, Cross R, Harris S, Kaye P, Burt AD, Ryder SD, Aithal GP, Day CP, Rosenberg WM. Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers. Hepatology 2008; 47: 455-460 [PMID: 18038452 DOI: 10.1002/hep.21984] (Pubitemid 351280713)
-
(2008)
Hepatology
, vol.47
, Issue.2
, pp. 455-460
-
-
Guha, I.N.1
Parkes, J.2
Roderick, P.3
Chattopadhyay, D.4
Cross, R.5
Harris, S.6
Kaye, P.7
Burt, A.D.8
Ryder, S.D.9
Aithal, G.P.10
Day, C.P.11
Rosenberg, W.M.12
-
106
-
-
84904763226
-
Serum cytokeratin-18 in the diagnosis of non-alcoholic steatohepatitis: A metaanalysis
-
Jul 9; Epub ahead of print PMID: 23834322
-
Chen J, Zhu Y, Zheng Q, Jiang J. Serum cytokeratin-18 in the diagnosis of non-alcoholic steatohepatitis: A metaanalysis. Hepatol Res 2013 Jul 9; Epub ahead of print [PMID: 23834322 DOI: 10.1111/hepr.12197]
-
(2013)
Hepatol Res
-
-
Chen, J.1
Zhu, Y.2
Zheng, Q.3
Jiang, J.4
-
107
-
-
84861591910
-
The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology
-
PMID: 22656328
-
Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 2012; 142: 1592-1609 [PMID: 22656328 DOI: 10.1053/j.gastro.2012.04.001]
-
(2012)
Gastroenterology
, vol.142
, pp. 1592-1609
-
-
Chalasani, N.1
Younossi, Z.2
Lavine, J.E.3
Diehl, A.M.4
Brunt, E.M.5
Cusi, K.6
Charlton, M.7
Sanyal, A.J.8
-
108
-
-
39549092421
-
Behavior therapy for nonalcoholic fatty liver disease: The need for a multidisciplinary approach
-
DOI 10.1002/hep.22009
-
Bellentani S, Dalle Grave R, Suppini A, Marchesini G. Behavior therapy for nonalcoholic fatty liver disease: The need for a multidisciplinary approach. Hepatology 2008; 47: 746-754 [PMID: 18098321 DOI: 10.1002/hep.22009] (Pubitemid 351280743)
-
(2008)
Hepatology
, vol.47
, Issue.2
, pp. 746-754
-
-
Bellentani, S.1
Grave, R.D.2
Suppini, A.3
Marchesini, G.4
Bedogni, G.5
Bugianesi, E.6
Croce, L.S.7
Gastaldelli, A.8
Marra, F.9
Perseghin, G.10
Svegliati-Baroni, G.11
Tell, G.12
Tiribelli, C.13
-
109
-
-
47149086771
-
Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: A randomized, controlled trial
-
DOI 10.1002/hep.22336
-
Nobili V, Manco M, Devito R, Di Ciommo V, Comparcola D, Sartorelli MR, Piemonte F, Marcellini M, Angulo P. Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial. Hepatology 2008; 48: 119-128 [PMID: 18537181 DOI: 10.1002/hep.22336] (Pubitemid 351975537)
-
(2008)
Hepatology
, vol.48
, Issue.1
, pp. 119-128
-
-
Nobili, V.1
Manco, M.2
Devito, R.3
Di, C.V.4
Comparcola, D.5
Sartorelli, M.R.6
Piemonte, F.7
Marcellini, M.8
Angulo, P.9
-
110
-
-
84862517200
-
Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of randomised trials
-
PMID: 22278337
-
Musso G, Cassader M, Rosina F, Gambino R. Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials. Diabetologia 2012; 55: 885-904 [PMID: 22278337 DOI: 10.1007/s00125-011-2446-4]
-
(2012)
Diabetologia
, vol.55
, pp. 885-904
-
-
Musso, G.1
Cassader, M.2
Rosina, F.3
Gambino, R.4
-
111
-
-
79952361224
-
Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease
-
quiz 469 PMID: 21206486
-
Kistler KD, Brunt EM, Clark JM, Diehl AM, Sallis JF, Schwimmer JB. Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease. Am J Gastroenterol 2011; 106: 460-48; quiz 469 [PMID: 21206486 DOI: 10.1038/ajg.2010.488]
-
(2011)
Am J Gastroenterol
, vol.106
, pp. 460-548
-
-
Kistler, K.D.1
Brunt, E.M.2
Clark, J.M.3
Diehl, A.M.4
Sallis, J.F.5
Schwimmer, J.B.6
-
112
-
-
80051545931
-
Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss
-
PMID: 21708823
-
Hallsworth K, Fattakhova G, Hollingsworth KG, Thoma C, Moore S, Taylor R, Day CP, Trenell MI. Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss. Gut 2011; 60: 1278-1283 [PMID: 21708823 DOI: 10.1136/gut.2011.242073]
-
(2011)
Gut
, vol.60
, pp. 1278-1283
-
-
Hallsworth, K.1
Fattakhova, G.2
Hollingsworth, K.G.3
Thoma, C.4
Moore, S.5
Taylor, R.6
Day, C.P.7
Trenell, M.I.8
-
113
-
-
84884984755
-
Both resistance training and aerobic training reduce hepatic fat content in type 2 diabetic subjects with nonalcoholic fatty liver disease
-
the RAED2 Randomized Trial PMID: 23504926
-
Bacchi E, Negri C, Targher G, Faccioli N, Lanza M, Zoppini G, Zanolin E, Schena F, Bonora E, Moghetti P. Both resistance training and aerobic training reduce hepatic fat content in type 2 diabetic subjects with nonalcoholic fatty liver disease (the RAED2 Randomized Trial). Hepatology 2013; 58: 1287-1295 [PMID: 23504926 DOI: 10.1002/hep.26393]
-
(2013)
Hepatology
, vol.58
, pp. 1287-1295
-
-
Bacchi, E.1
Negri, C.2
Targher, G.3
Faccioli, N.4
Lanza, M.5
Zoppini, G.6
Zanolin, E.7
Schena, F.8
Bonora, E.9
Moghetti, P.10
-
114
-
-
67650951419
-
Prospective study of the longterm effects of bariatric surgery on liver injury in patients without advanced disease
-
PMID: 19409898
-
Mathurin P, Hollebecque A, Arnalsteen L, Buob D, Leteurtre E, Caiazzo R, Pigeyre M, Verkindt H, Dharancy S, Louvet A, Romon M, Pattou F. Prospective study of the longterm effects of bariatric surgery on liver injury in patients without advanced disease. Gastroenterology 2009; 137: 532-540 [PMID: 19409898 DOI: 10.1053/j.gastro.2009.04.052]
-
(2009)
Gastroenterology
, vol.137
, pp. 532-540
-
-
Mathurin, P.1
Hollebecque, A.2
Arnalsteen, L.3
Buob, D.4
Leteurtre, E.5
Caiazzo, R.6
Pigeyre, M.7
Verkindt, H.8
Dharancy, S.9
Louvet, A.10
Romon, M.11
Pattou, F.12
-
115
-
-
57149101692
-
Effect of bariatric surgery on nonalcoholic fatty liver disease: Systematic review and meta-analysis
-
PMID: 18986848
-
Mummadi RR, Kasturi KS, Chennareddygari S, Sood GK. Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol 2008; 6: 1396-1402 [PMID: 18986848 DOI: 10.1016/j.cgh.2008.08.012]
-
(2008)
Clin Gastroenterol Hepatol
, vol.6
, pp. 1396-1402
-
-
Mummadi, R.R.1
Kasturi, K.S.2
Chennareddygari, S.3
Sood, G.K.4
-
116
-
-
84858703583
-
Omega-3 supplementation and non-alcoholic fatty liver disease: A systematic review and meta-analysis
-
PMID: 22023985
-
Parker HM, Johnson NA, Burdon CA, Cohn JS, O'Connor HT, George J. Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis. J Hepatol 2012; 56: 944-951 [PMID: 22023985 DOI: 10.1016/j.jhep.2011.08.018]
-
(2012)
J Hepatol
, vol.56
, pp. 944-951
-
-
Parker, H.M.1
Johnson, N.A.2
Burdon, C.A.3
Cohn, J.S.4
O'Connor, H.T.5
George, J.6
-
117
-
-
78650971903
-
Atorvastatin and antioxidants for the treatment of nonalcoholic fatty liver disease: The St Francis Heart Study randomized clinical trial
-
PMID: 20842109
-
Foster T, Budoff MJ, Saab S, Ahmadi N, Gordon C, Guerci AD. Atorvastatin and antioxidants for the treatment of nonalcoholic fatty liver disease: the St Francis Heart Study randomized clinical trial. Am J Gastroenterol 2011; 106: 71-77 [PMID: 20842109 DOI: 10.1038/ajg.2010.299]
-
(2011)
Am J Gastroenterol
, vol.106
, pp. 71-77
-
-
Foster, T.1
Budoff, M.J.2
Saab, S.3
Ahmadi, N.4
Gordon, C.5
Guerci, A.D.6
-
118
-
-
79953880237
-
Statin-based treatment for cardiovascular risk and non-alcoholic fatty liver disease. Killing two birds with one stone?
-
PMID: 21476786
-
Athyros VG, Tziomalos K, Daskalopoulos GN, Karagiannis A, Mikhailidis DP. Statin-based treatment for cardiovascular risk and non-alcoholic fatty liver disease. Killing two birds with one stone? Ann Med 2011; 43: 167-171 [PMID: 21476786 DOI: 10.3109/07853890.2011.561363]
-
(2011)
Ann Med
, vol.43
, pp. 167-171
-
-
Athyros, V.G.1
Tziomalos, K.2
Daskalopoulos, G.N.3
Karagiannis, A.4
Mikhailidis, D.P.5
-
119
-
-
1542515099
-
Ursodeoxycholic Acid for Treatment of Nonalcoholic Steatohepatitis: Results of a Randomized Trial
-
DOI 10.1002/hep.20092
-
Lindor KD, Kowdley KV, Heathcote EJ, Harrison ME, Jorgensen R, Angulo P, Lymp JF, Burgart L, Colin P. Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial. Hepatology 2004; 39: 770-778 [PMID: 14999696 DOI: 10.1002/hep.20092] (Pubitemid 38337657)
-
(2004)
Hepatology
, vol.39
, Issue.3
, pp. 770-778
-
-
Lindor, K.D.1
Kowdley, K.V.2
Heathcote, E.J.3
Harrison, M.E.4
Jorgensen, R.5
Angulo, P.6
Lymp, J.F.7
Burgart, L.8
Colin, P.9
-
120
-
-
77955699301
-
High-dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: A double-blind, randomized, placebo-controlled trial
-
PMID: 20683947
-
Leuschner UF, Lindenthal B, Herrmann G, Arnold JC, Rössle M, Cordes HJ, Zeuzem S, Hein J, Berg T. High-dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: a double-blind, randomized, placebo-controlled trial. Hepatology 2010; 52: 472-479 [PMID: 20683947 DOI: 10.1002/hep.23727]
-
(2010)
Hepatology
, vol.52
, pp. 472-479
-
-
Leuschner, U.F.1
Lindenthal, B.2
Herrmann, G.3
Arnold, J.C.4
Rössle, M.5
Cordes, H.J.6
Zeuzem, S.7
Hein, J.8
Berg, T.9
-
121
-
-
1642296465
-
Metformin in the treatment of patients with non-alcoholic steatohepatitis
-
DOI 10.1111/j.1365-2036.2004.01888.x
-
Uygun A, Kadayifci A, Isik AT, Ozgurtas T, Deveci S, Tuzun A, Yesilova Z, Gulsen M, Dagalp K. Metformin in the treatment of patients with non-alcoholic steatohepatitis. Aliment Pharmacol Ther 2004; 19: 537-544 [PMID: 14987322] (Pubitemid 38387180)
-
(2004)
Alimentary Pharmacology and Therapeutics
, vol.19
, Issue.5
, pp. 537-544
-
-
Uygun, A.1
Kadayifci, A.2
Isik, A.T.3
Ozgurtas, T.4
Deveci, S.5
Tuzun, A.6
Yesilova, Z.7
Gulsen, M.8
Dagalp, K.9
-
122
-
-
70350662659
-
Metformin in patients with non-alcoholic fatty liver disease: A randomized, controlled trial
-
PMID: 19811343
-
Haukeland JW, Konopski Z, Eggesbø HB, von Volkmann HL, Raschpichler G, Bjøro K, Haaland T, Løberg EM, Birkeland K. Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trial. Scand J Gastroenterol 2009; 44: 853-860 [PMID: 19811343 DOI: 10.1080/00365520902845268]
-
(2009)
Scand J Gastroenterol
, vol.44
, pp. 853-860
-
-
Haukeland, J.W.1
Konopski, Z.2
Eggesbø, H.B.3
Von Volkmann, H.L.4
Raschpichler, G.5
Bjøro, K.6
Haaland, T.7
Løberg, E.M.8
Birkeland, K.9
-
123
-
-
77953368192
-
The Effect of Metformin and Standard Therapy versus Standard Therapy alone in Nondiabetic Patients with Insulin Resistance and Nonalcoholic Steatohepatitis (NASH): A Pilot Trial
-
PMID: 21180541
-
Shields WW, Thompson KE, Grice GA, Harrison SA, Coyle WJ. The Effect of Metformin and Standard Therapy versus Standard Therapy alone in Nondiabetic Patients with Insulin Resistance and Nonalcoholic Steatohepatitis (NASH): A Pilot Trial. Therap Adv Gastroenterol 2009; 2: 157-163 [PMID: 21180541 DOI: 10.1177/1756283X09105462]
-
(2009)
Therap Adv Gastroenterol
, vol.2
, pp. 157-163
-
-
Shields, W.W.1
Thompson, K.E.2
Grice, G.A.3
Harrison, S.A.4
Coyle, W.J.5
-
124
-
-
77951006620
-
Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma
-
PMID: 20166205
-
Hassan MM, Curley SA, Li D, Kaseb A, Davila M, Abdalla EK, Javle M, Moghazy DM, Lozano RD, Abbruzzese JL, Vauthey JN. Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma. Cancer 2010; 116: 1938-1946 [PMID: 20166205 DOI: 10.1002/cncr.24982]
-
(2010)
Cancer
, vol.116
, pp. 1938-1946
-
-
Hassan, M.M.1
Curley, S.A.2
Li, D.3
Kaseb, A.4
Davila, M.5
Abdalla, E.K.6
Javle, M.7
Moghazy, D.M.8
Lozano, R.D.9
Abbruzzese, J.L.10
Vauthey, J.N.11
-
125
-
-
84855432249
-
Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: A populationbased cohort study
-
PMID: 22085817
-
Lai SW, Chen PC, Liao KF, Muo CH, Lin CC, Sung FC. Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a populationbased cohort study. Am J Gastroenterol 2012; 107: 46-52 [PMID: 22085817 DOI: 10.1038/ajg.2011.384]
-
(2012)
Am J Gastroenterol
, vol.107
, pp. 46-52
-
-
Lai, S.W.1
Chen, P.C.2
Liao, K.F.3
Muo, C.H.4
Lin, C.C.5
Sung, F.C.6
-
126
-
-
34548306770
-
The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis
-
DOI 10.1002/hep.21661
-
Lutchman G, Modi A, Kleiner DE, Promrat K, Heller T, Ghany M, Borg B, Loomba R, Liang TJ, Premkumar A, Hoofnagle JH. The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis. Hepatology 2007; 46: 424-429 [PMID: 17559148 DOI: 10.1002/hep.21661] (Pubitemid 47344777)
-
(2007)
Hepatology
, vol.46
, Issue.2
, pp. 424-429
-
-
Lutchman, G.1
Modi, A.2
Kleiner, D.E.3
Promrat, K.4
Heller, T.5
Ghany, M.6
Borg, B.7
Loomba, R.8
Liang, T.J.9
Premkumar, A.10
Hoofnagle, J.H.11
-
127
-
-
33751545838
-
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
-
DOI 10.1056/NEJMoa060326
-
Belfort R, Harrison SA, Brown K, Darland C, Finch J, Hardies J, Balas B, Gastaldelli A, Tio F, Pulcini J, Berria R, Ma JZ, Dwivedi S, Havranek R, Fincke C, DeFronzo R, Bannayan GA, Schenker S, Cusi K. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. N Engl J Med 2006; 355: 2297-2307 [PMID: 17135584 DOI: 10.1056/NEJMoa060326] (Pubitemid 44837778)
-
(2006)
New England Journal of Medicine
, vol.355
, Issue.22
, pp. 2297-2307
-
-
Belfort, R.1
Harrison, S.A.2
Brown, K.3
Darland, C.4
Finch, J.5
Hardies, J.6
Balas, B.7
Gastaldelli, A.8
Tio, F.9
Pulcini, J.10
Berria, R.11
Ma, J.Z.12
Dwivedi, S.13
Havranek, R.14
Fincke, C.15
DeFronzo, R.16
Bannayan, G.A.17
Schenker, S.18
Cusi, K.19
-
128
-
-
53049101877
-
Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis
-
PMID: 18718471
-
Aithal GP, Thomas JA, Kaye PV, Lawson A, Ryder SD, Spendlove I, Austin AS, Freeman JG, Morgan L, Webber J. Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis. Gastroenterology 2008; 135: 1176-1184 [PMID: 18718471 DOI: 10.1053/j.gastro.2008.06.047]
-
(2008)
Gastroenterology
, vol.135
, pp. 1176-1184
-
-
Aithal, G.P.1
Thomas, J.A.2
Kaye, P.V.3
Lawson, A.4
Ryder, S.D.5
Spendlove, I.6
Austin, A.S.7
Freeman, J.G.8
Morgan, L.9
Webber, J.10
-
129
-
-
77951874018
-
Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis
-
PMID: 20427778
-
Sanyal AJ, Chalasani N, Kowdley KV, McCullough A, Diehl AM, Bass NM, Neuschwander-Tetri BA, Lavine JE, Tonascia J, Unalp A, Van Natta M, Clark J, Brunt EM, Kleiner DE, Hoofnagle JH, Robuck PR. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med 2010; 362: 1675-1685 [PMID: 20427778 DOI: 10.1056/NEJMoa0907929]
-
(2010)
N Engl J Med
, vol.362
, pp. 1675-1685
-
-
Sanyal, A.J.1
Chalasani, N.2
Kowdley, K.V.3
McCullough, A.4
Diehl, A.M.5
Bass, N.M.6
Neuschwander-Tetri, B.A.7
Lavine, J.E.8
Tonascia, J.9
Unalp, A.10
Van Natta, M.11
Clark, J.12
Brunt, E.M.13
Kleiner, D.E.14
Hoofnagle, J.H.15
Robuck, P.R.16
-
130
-
-
0032934104
-
Effects of a thiazolidinedione compound on body fat and fat distribution of patients with type 2 diabetes
-
DOI 10.2337/diacare.22.2.288
-
Kelly IE, Han TS, Walsh K, Lean ME. Effects of a thiazolidinedione compound on body fat and fat distribution of patients with type 2 diabetes. Diabetes Care 1999; 22: 288-293 [PMID: 10333947] (Pubitemid 29056924)
-
(1999)
Diabetes Care
, vol.22
, Issue.2
, pp. 288-293
-
-
Kelly, I.E.1
Han, T.S.2
Walsh, K.3
Lean, M.E.J.4
-
131
-
-
79953236112
-
Thiazolidinediones and risk of heart failure in patients with or at high risk of type 2 diabetes mellitus: A meta-analysis and meta-regression analysis of placebo-controlled randomized clinical trials
-
PMID: 21294599
-
Hernandez AV, Usmani A, Rajamanickam A, Moheet A. Thiazolidinediones and risk of heart failure in patients with or at high risk of type 2 diabetes mellitus: a meta-analysis and meta-regression analysis of placebo-controlled randomized clinical trials. Am J Cardiovasc Drugs 2011; 11: 115-128 [PMID: 21294599 DOI: 10.2165/11587580-000000000-00000]
-
(2011)
Am J Cardiovasc Drugs
, vol.11
, pp. 115-128
-
-
Hernandez, A.V.1
Usmani, A.2
Rajamanickam, A.3
Moheet, A.4
-
132
-
-
79956217900
-
Risk of bladder cancer among diabetic patients treated with pioglitazone: Interim report of a longitudinal cohort study
-
PMID: 21447663
-
Lewis JD, Ferrara A, Peng T, Hedderson M, Bilker WB, Quesenberry CP, Vaughn DJ, Nessel L, Selby J, Strom BL. Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study. Diabetes Care 2011; 34: 916-922 [PMID: 21447663 DOI: 10.2337/dc10-1068]
-
(2011)
Diabetes Care
, vol.34
, pp. 916-922
-
-
Lewis, J.D.1
Ferrara, A.2
Peng, T.3
Hedderson, M.4
Bilker, W.B.5
Quesenberry, C.P.6
Vaughn, D.J.7
Nessel, L.8
Selby, J.9
Strom, B.L.10
-
133
-
-
79956114434
-
Glucagonlike peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase
-
PMID: 21145820
-
Ben-Shlomo S, Zvibel I, Shnell M, Shlomai A, Chepurko E, Halpern Z, Barzilai N, Oren R, Fishman S. Glucagonlike peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase. J Hepatol 2011; 54: 1214-1223 [PMID: 21145820 DOI: 10.1016/j.jhep.2010.09.032]
-
(2011)
J Hepatol
, vol.54
, pp. 1214-1223
-
-
Ben-Shlomo, S.1
Zvibel, I.2
Shnell, M.3
Shlomai, A.4
Chepurko, E.5
Halpern, Z.6
Barzilai, N.7
Oren, R.8
Fishman, S.9
-
134
-
-
80052517174
-
Glucagonlike peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis
-
PMID: 21745271
-
Svegliati-Baroni G, Saccomanno S, Rychlicki C, Agostinelli L, De Minicis S, Candelaresi C, Faraci G, Pacetti D, Vivarelli M, Nicolini D, Garelli P, Casini A, Manco M, Mingrone G, Risaliti A, Frega GN, Benedetti A, Gastaldelli A. Glucagonlike peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis. Liver Int 2011; 31: 1285-1297 [PMID: 21745271 DOI: 10.1111/j.1478-3231.2011.02462.x]
-
(2011)
Liver Int
, vol.31
, pp. 1285-1297
-
-
Svegliati-Baroni, G.1
Saccomanno, S.2
Rychlicki, C.3
Agostinelli, L.4
De Minicis, S.5
Candelaresi, C.6
Faraci, G.7
Pacetti, D.8
Vivarelli, M.9
Nicolini, D.10
Garelli, P.11
Casini, A.12
Manco, M.13
Mingrone, G.14
Risaliti, A.15
Frega, G.N.16
Benedetti, A.17
Gastaldelli, A.18
-
135
-
-
84859003663
-
Effects of glucagon-like peptide-1 receptor agonists on weight loss: Systematic review and meta-analyses of randomised controlled trials
-
PMID: 22236411
-
Vilsbøll T, Christensen M, Junker AE, Knop FK, Gluud LL. Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials. BMJ 2012; 344: d7771 [PMID: 22236411 DOI: 10.1136/bmj.d7771]
-
(2012)
BMJ
, vol.344
, pp. d7771
-
-
Vilsbøll, T.1
Christensen, M.2
Junker, A.E.3
Knop, F.K.4
Gluud, L.L.5
-
136
-
-
19944427642
-
Meta-analysis: High-dosage vitamin E supplementation may increase all-cause mortality
-
PMID: 15537682
-
Miller ER, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 2005; 142: 37-46 [PMID: 15537682 DOI: 10.7326/0003-4819-142-1-200501040-00110]
-
(2005)
Ann Intern Med
, vol.142
, pp. 37-46
-
-
Miller, E.R.1
Pastor-Barriuso, R.2
Dalal, D.3
Riemersma, R.A.4
Appel, L.J.5
Guallar, E.6
-
137
-
-
84885405205
-
Dual peroxisome proliferator-activated receptor α/δ agonist GFT505 improves hepatic and peripheral insulin sensitivity in abdominally obese subjects
-
PMID: 23715754
-
Cariou B, Hanf R, Lambert-Porcheron S, Zaïr Y, Sauvinet V, Noël B, Flet L, Vidal H, Staels B, Laville M. Dual peroxisome proliferator-activated receptor α/δ agonist GFT505 improves hepatic and peripheral insulin sensitivity in abdominally obese subjects. Diabetes Care 2013; 36: 2923-2930 [PMID: 23715754 DOI: 10.2337/dc12-2012]
-
(2013)
Diabetes Care
, vol.36
, pp. 2923-2930
-
-
Cariou, B.1
Hanf, R.2
Lambert-Porcheron, S.3
Zaïr, Y.4
Sauvinet, V.5
Noël, B.6
Flet, L.7
Vidal, H.8
Staels, B.9
Laville, M.10
-
138
-
-
84880664792
-
Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease
-
PMID: 23727264
-
Mudaliar S, Henry RR, Sanyal AJ, Morrow L, Marschall HU, Kipnes M, Adorini L, Sciacca CI, Clopton P, Castelloe E, Dillon P, Pruzanski M, Shapiro D. Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease. Gastroenterology 2013; 145: 574-82.e1 [PMID: 23727264 DOI: 10.1053/j.gastro.2013.05.042]
-
(2013)
Gastroenterology
, vol.145
, pp. 574-82.e1
-
-
Mudaliar, S.1
Henry, R.R.2
Sanyal, A.J.3
Morrow, L.4
Marschall, H.U.5
Kipnes, M.6
Adorini, L.7
Sciacca, C.I.8
Clopton, P.9
Castelloe, E.10
Dillon, P.11
Pruzanski, M.12
Shapiro, D.13
|